July 29, 2013

Herbalife Ltd. Announces Record Second Quarter 2013 and Raises 2013 Earnings Guidance

  • Second quarter worldwide volume growth of 14 percent compared to the prior year period.
  • Second quarter adjusted1 EPS of $1.41 increased 29 percent compared to the prior year period.
  • Raising FY'13 adjusted EPS guidance to a range of $4.83 to $4.95.
  • Generated $214 million in operating cash flow during the second quarter
  • Board of directors approved a $0.30 per share quarterly dividend.

LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE: HLF) today reported second quarter net sales of $1.2 billion, reflecting an increase of 18 percent compared to the same time period in 2012, on volume point growth of 14 percent. Adjusted1 net income for the quarter of $150.7 million, or $1.41 per diluted share, compares to the second quarter 2012 net income of $132.0 million and EPS of $1.09, respectively. On an as reported basis, second quarter 2013 EPS of $1.34 increased 23 percent compared to the $1.09 reported in the comparable quarter last year.

"We reported our fifteenth quarter in a row of double digit top-line growth, reflecting the success that our products and distribution model are having in markets around the world helping to mitigate the adverse effects of the obesity epidemic. The second quarter record results for volume point and net sales were driven by the ongoing engagement of our distributors and consumer demand for our weight loss and nutrition products worldwide," said Michael O. Johnson, Herbalife's chairman and CEO.

For the quarter ended June 30, 2013 the company generated cash flow from operations of $213.8 million, an increase of 56 percent compared to 2012; paid dividends of $30.9 million and invested $31.3 million in capital expenditures.

Second Quarter 2013 Key Metrics2,3

Regional Volume Point and Average Active Sales Leader Metrics

  Volume Points (Mil)   Average Active Sales Leaders
Region   2Q'13   Yr/Yr % Chg   2Q'13   Yr/Yr % Chg
North America 339.9   11 % 72,282   10 %
Asia Pacific 316.9 1 % 70,802 15 %
EMEA 179.3 16 % 48,008 12 %
Mexico 219.9 8 % 62,940 13 %
South & Central America 222.6 33 % 54,614 30 %
China   85.9   49 %   14,070   18 %
Worldwide Total   1,364.5   14 %   311,503   15 %
 

Updated 2013 Guidance

Guidance for fully diluted 2013 EPS is based on the average daily exchange rates of the first two weeks of July 2013. Our 2013 guidance continues to assume a Venezuelan exchange rate of 10 to 1 for the balance of the year, excludes the impact of the February devaluation of the bolivar as well as any potential future devaluation, and excludes the impact of any repatriation of existing cash balances in Venezuela. Guidance for the year also excludes the following which were recognized in the first half of the year: $15.1 million in expenses (post-tax), mostly legal and advisory services relating to the Company's response to information put into the marketplace by a short seller which information the Company believes to be inaccurate and misleading, and $2.7 million in expenses (post-tax) incurred for the re-audit of 2010-2012 financial statements resulting from KPMG LLP's resignation, as well as any additional expenses related to these matters that are expected to be incurred in the second half of the year.

Based on current business trends the company's third quarter fiscal 2013 and full year fiscal 2013 guidance is provided below.

Three Months Ending   Twelve Months Ending

September 30, 2013

December 31, 2013

Low   High Low   High
Volume Point Growth vs 2012 11.5 % 13.5 % 11.5 % 13.5 %
Net Sales Growth vs 2012 16.5 % 18.5 % 16.0 % 18.0 %
Diluted EPS as adjusted $ 1.09 $ 1.13 $ 4.83 $ 4.95
Cap Ex ($ millions) $ 40.0 $ 50.0 $ 165.0 $ 185.0
Effective Tax Rate 22.5 % 24.5 % 24.5 %

26.5

%
 

Announces Quarterly Dividend

The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record August 13, 2013, payable on August 27, 2013.

Second Quarter 2013 Earnings Conference Call

Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, July 30, 2013 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 11550232). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 11550232). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in over 80 countries through and to a network of independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

FORWARD-LOOKING STATEMENTS

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

• the resignation of our former independent registered public accounting firm, its withdrawal of its audit reports with respect to certain of our historical financial statements, and any difficulties PricewaterhouseCoopers, our successor accounting firm encounters in the re-audits of such relevant historical financial statements or any material modifications to such historical financial statements PricewaterhouseCoopers believes should be made as a result of such re-audits;

• any collateral impact resulting from the ongoing worldwide financial environment, including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a difficult economic environment;

• our relationship with, and our ability to influence the actions of, our distributors;

• improper action by our employees or distributors in violation of applicable law;

• adverse publicity associated with our products or network marketing organization, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;

• changing consumer preferences and demands;

• our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our distributor relations and operating results;

• the competitive nature of our business;

• regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products and network marketing program, including the direct selling market in which we operate;

• legal challenges to our network marketing program;

• risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with our third party importers, pricing and currency devaluation risks, especially in countries such as Venezuela;

• uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;

• uncertainties relating to interpretation and enforcement of legislation in China governing direct selling;

• uncertainties relating to the interpretation, enforcement or amendment of legislation in India governing direct selling;

• our inability to obtain the necessary licenses to expand our direct selling business in China;

• adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;

• our dependence on increased penetration of existing markets;

• contractual limitations on our ability to expand our business;

• our reliance on our information technology infrastructure and outside manufacturers;

• the sufficiency of trademarks and other intellectual property rights;

• product concentration;

• changes in tax laws, treaties or regulations, or their interpretation;

• taxation relating to our distributors;

• product liability claims;

• whether we will purchase any of our shares in the open markets or otherwise; and

• share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.

We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

1 See Schedule A — "Reconciliation of Non-GAAP Financial Measures" for more detail.

2 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.

3 Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.

RESULTS OF OPERATIONS:

                     
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited and Unreviewed) (1)
                   
Three Months Ended Six Months Ended
6/30/2013  

6/30/2012 (2)

 

 

6/30/2013    

6/30/2012 (2)

 
North America $ 247,564 $ 224,661 $ 469,037 $ 435,372
Mexico 145,638 119,449 278,527 236,558
South and Central America 222,362 152,583 441,877 318,054
EMEA 186,286 161,635 355,871 315,627
Asia Pacific 299,240 296,548 610,986 556,496
China   118,149   77,072   186,588   134,016  
Worldwide net sales 1,219,239 1,031,948 2,342,886 1,996,123
Cost of Sales   247,224   203,737   473,201   399,881  
Gross Profit 972,015 828,211 1,869,685 1,596,242
Royalty Overrides 379,551 335,195 743,580 652,728
SGA   400,107   306,310   764,827   602,703  
Operating Income 192,357 186,706 361,278 340,811
Interest Expense - net   5,559   3,169   10,932   4,542  
Income before income taxes 186,798 183,537 350,346 336,269
Income Taxes   43,636   51,586   88,311   96,387  
Net Income   143,162   131,951   262,035   239,882  
 
Basic Shares 102,993 116,557 103,551 116,376
Diluted Shares 107,083 121,482 107,589 122,182
 
Basic EPS $ 1.39 $ 1.13 $ 2.53 $ 2.06  
Diluted EPS $ 1.34 $ 1.09 $ 2.44 $ 1.96  
 
Dividends declared per share $ 0.30 $ 0.30 $ 0.60 $ 0.60  
                     
 

(1) As a result of the resignation of KPMG, the unaudited interim financial information presented has not been reviewed by an outside independent accounting firm. See Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013.

(2) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013, prior year amounts have been revised for income tax errors that were considered not material, individually or in the aggregate, to any of the prior reporting periods.

 

       
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands)

(Unaudited and Unreviewed) (1)

 
Jun 30,   Dec 31,
2013

2012 (2)

 
ASSETS
Current Assets:
Cash & cash equivalents $ 849,703 $ 333,534
Receivables, net 110,790 116,139
Inventories 331,529 339,411
Prepaid expenses and other current assets 160,444 145,624
Deferred income taxes   51,499     49,339  
Total Current Assets 1,503,965 984,047
 
Property, plant and equipment, net 255,206 242,886
Deferred compensation plan assets 24,934 24,267
Deferred financing cost, net 6,165 7,462
Other assets 47,250 48,805
Marketing related intangibles and other intangible assets, net 310,993 311,186
Goodwill   105,490     105,490  
Total Assets $ 2,254,003   $ 1,724,143  
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 77,535 $ 75,209
Royalty overrides 235,994 243,351
Accrued compensation 82,113 95,220
Accrued expenses 227,468 181,523
Current portion of long term debt 68,819 56,302
Advance sales deposits 51,574 49,432
Income taxes payable   48,751     61,325  
Total Current Liabilities 792,254 762,362
 
Non-current liabilities
Long-term debt, net of current portion 893,767 431,305
Deferred compensation plan liability 32,981 29,454
Deferred income taxes 60,033 62,982
Other non-current liabilities   41,349     42,557  
Total Liabilities 1,820,384 1,328,660
 
Contingencies
 
Shareholders' equity:
Common shares 103 107
Paid-in capital in excess of par value 305,742 303,975
Accumulated other comprehensive loss (44,283 ) (31,695 )
Retained earnings   172,057     123,096  
Total Shareholders' Equity   433,619     395,483  
   
Total Liabilities and Shareholders' Equity $ 2,254,003   $ 1,724,143  
       
 
(1) As a result of the resignation of KPMG, the unaudited interim financial information presented has not been reviewed by an outside independent accounting firm. See Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013.
(2) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013, prior year amounts have been revised for income tax errors that were considered not material, individually or in the aggregate, to any of the prior reporting periods.
 

             
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In thousands)

(Unaudited and Unreviewed)(1)

 

           
Six Months Ended
  6/30/2013      

6/30/2012 (2)

 

CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 262,035 $ 239,882
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 42,310 36,613
Excess tax benefits from share-based payment arrangements (15 ) (27,212 )
Share based compensation expenses 15,253 12,497
Amortization of deferred financing costs 1,295 572
Deferred income taxes (7,939 ) (8,476 )
Unrealized foreign exchange transaction (gain) loss (44 ) (4,909 )
Foreign exchange loss from Venezuela currency devaluation 15,116 -
Other (674 ) 120
Changes in operating assets and liabilities:
Receivables (312 ) (21,317 )
Inventories (3,646 ) (14,476 )
Prepaid expenses and other current assets (13,150 ) (9,367 )
Other assets (534 ) (3,124 )
Accounts payable 4,586 22,948
Royalty overrides (2,051 ) 7,932
Accrued expenses and accrued compensation 43,761 (3,516 )
Advance sales deposits 4,481 5,199
Income taxes (12,546 ) 20,661
Deferred compensation plan liability   3,527     3,416  
NET CASH PROVIDED BY OPERATING ACTIVITIES   351,453     257,443  
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (56,048 ) (39,719 )
Proceeds from sale of property, plant and equipment 33 43
Deferred compensation plan assets   -     (2,609 )
NET CASH USED IN INVESTING ACTIVITIES   (56,015 )   (42,285 )
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid (61,823 ) (70,310 )
Borrowings from long-term debt 513,227 806,560
Principal payments on long-term debt (38,250 ) (454,371 )
Share repurchases (165,726 ) (505,636 )
Excess tax benefits from share-based payment arrangements 15 27,212
Proceeds from exercise of stock options and sale of stock under
employee stock purchase plan   971     10,356  
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   248,414     (186,189 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (27,683 )   (1,578 )
NET CHANGE IN CASH AND CASH EQUIVALENTS 516,169 27,391
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   333,534     258,775  
CASH AND CASH EQUIVALENTS, END OF PERIOD   849,703     286,166  
CASH PAID DURING THE YEAR
Interest paid $ 12,004   $ 5,884  
Income taxes paid $ 117,120   $ 86,214  
             
(1) As a result of the resignation of KPMG, the unaudited interim financial information presented has not been reviewed by an outside independent accounting firm. See Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013.
(2) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013, prior year amounts have been revised for income tax errors that were considered not material, individually or in the aggregate, to any of the prior reporting periods.
 

SUPPLEMENTAL INFORMATION

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited and unreviewed), (Dollars in Thousand, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as "non-GAAP financial measures." Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investors in analyzing period to period comparisons of the Company's results.

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:
               
     
Three Months Ended Six Months Ended
  6/30/2013    

6/30/2012 (3)

 

  6/30/2013  

6/30/2012 (3)

 

(in thousands)
 
Net income, as reported $ 143,162 $ 131,951 $ 262,035 $ 239,882
Venezuela devaluation impact (net of $2,217 and $6,808 tax benefit for the
three and six months ended June 30, 2013, respectively) (1)(2) (2,217 ) - 8,307 -
Expenses incurred responding to attacks on the Company's business
model (net of $953 and $2,468 tax benefit for the three and six months
ended June 30, 2013, respectively)(1) 7,125 - 15,104 -
Expenses incurred for the re-audit of 2010 to 2012 financial statements due to
resignation of KPMG (net of $796 tax benefit for the three and six months
ended June 30, 2013)(1)   2,661     -     2,661   -  
Net income, as adjusted $ 150,731   $ 131,951   $ 288,107 $ 239,882  
               
 
The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:
               
 
Three Months Ended Six Months Ended
  6/30/2013    

6/30/2012 (3)

 

  6/30/2013  

6/30/2012 (3)

 

 
Diluted earnings per share, as reported $ 1.34 $ 1.09 $ 2.44 $ 1.96
Venezuela devaluation impact (net of $2,217 and $6,808 tax benefit for the
three and six months ended June 30, 2013, respectively) (1) (0.02 ) - 0.08 -
Expenses incurred responding to attacks on the Company's business
model (net of $953 and $2,468 tax benefit for the three and six months
ended June 30, 2013, respectively)(1) 0.07 - 0.14 -
Expenses incurred for the re-audit of 2010 to 2012 financial statements due to
resignation of KPMG (net of $796 tax benefit for the three and six months
ended June 30, 2013)(1)   0.02     -     0.02   -  
Diluted earnings per share, as adjusted $ 1.41   $ 1.09   $ 2.68 $ 1.96  
               
 
(1) The income tax impact of the non-GAAP adjustments is based on forecasted items affecting the Company's 2013 full year GAAP effective tax rate. Adjustments to forecasted items unrelated to these non-GAAP adjustments may have an effect on the income tax impact of the non-GAAP adjustments in subsequent periods.
(2) The amount for the three months ended June 30, 2013 relates to the change in tax benefit, as explained in note 1, for the Venezuela devaluation that was recorded in the first quarter.
(3) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended June 30, 2013, prior year amounts have been revised for income tax errors that were considered not material, individually or in the aggregate, to any of the prior reporting periods.
 

The following is a reconciliation of total long-term debt to net debt:

           
    6/30/2013     12/31/2012
 
Total long-term debt (current and long-term portion) $ 962,586 $ 487,607
Less: Cash and cash equivalents   849,703   333,534
Net debt $ 112,883 $ 154,073
 

Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
213.745.0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
213.745.0474

Source: Herbalife Ltd.

News Provided by Acquire Media


Close window | Back to top

Copyright 2014 Herbalife Ltd.